Knee pain drug trial halted midway
NCT ID NCT05838742
First seen Nov 10, 2025 · Last updated May 14, 2026 · Updated 16 times
Summary
This study tested an experimental drug called GSK3858279 to see if it could reduce moderate to severe knee pain from osteoarthritis. About 314 adults aged 40 to 80 took part. The trial was stopped early, so we don't have final results on how well the drug worked or its safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Cerritos, California, 90703, United States
-
GSK Investigational Site
Huntington Beach, California, 92647, United States
-
GSK Investigational Site
Santa Clara, California, 95054, United States
-
GSK Investigational Site
Cooper City, Florida, 33024, United States
-
GSK Investigational Site
Cutler Bay, Florida, 33189, United States
-
GSK Investigational Site
Miami, Florida, 33173, United States
-
GSK Investigational Site
Miami, Florida, 33185, United States
-
GSK Investigational Site
Wichita, Kansas, 67207, United States
-
GSK Investigational Site
Louisville, Kentucky, 40213, United States
-
GSK Investigational Site
New Orleans, Louisiana, 70115, United States
-
GSK Investigational Site
Henderson, Nevada, 89052, United States
-
GSK Investigational Site
Williamsville, New York, 14221, United States
-
GSK Investigational Site
Greensboro, North Carolina, 27410, United States
-
GSK Investigational Site
Duncansville, Pennsylvania, 16635, United States
-
GSK Investigational Site
Charlottesville, Virginia, 22911, United States
-
GSK Investigational Site
Buenos Aires, C1128AAF, Argentina
-
GSK Investigational Site
Buenos Aires-San Isidro, 1643, Argentina
-
GSK Investigational Site
Ciudad Autonoma Buenos Aires, C1417, Argentina
-
GSK Investigational Site
Ciudad AutOnoma de Buenos Aire, 1118, Argentina
-
GSK Investigational Site
Ciudad Autonoma de Buenos Aire, C1046AAQ, Argentina
-
GSK Investigational Site
Mar del Plata, B7600FYK, Argentina
-
GSK Investigational Site
Botany, New South Wales, 2019, Australia
-
GSK Investigational Site
Kotara, New South Wales, 2289, Australia
-
GSK Investigational Site
Sydney, New South Wales, 2010, Australia
-
GSK Investigational Site
Camberwell, Victoria, 3124, Australia
-
GSK Investigational Site
Victoria, British Columbia, V8V 4A1, Canada
-
GSK Investigational Site
Brampton, Ontario, L6T 0G1, Canada
-
GSK Investigational Site
Guelph, Ontario, N1H 1B1, Canada
-
GSK Investigational Site
Sarnia, Ontario, N7T 4X3, Canada
-
GSK Investigational Site
Toronto, Ontario, M5T 2S8, Canada
-
GSK Investigational Site
Toronto, Ontario, M9V 4B4, Canada
-
GSK Investigational Site
Winchester, Ontario, K0C 2K0, Canada
-
GSK Investigational Site
Joliette, Quebec, J6E 6A9, Canada
-
GSK Investigational Site
Sherbrooke, Quebec, J1L 0H8, Canada
-
GSK Investigational Site
Trois-Rivières, Quebec, G9A 3X2, Canada
-
GSK Investigational Site
Beijing, 100083, China
-
GSK Investigational Site
Beijing, 100730, China
-
GSK Investigational Site
Changchun, 130021, China
-
GSK Investigational Site
Chengdu, 610041, China
-
GSK Investigational Site
Guangzhou, 510000, China
-
GSK Investigational Site
Hohhot, 010017, China
-
GSK Investigational Site
Nanjing, 210009, China
-
GSK Investigational Site
Shanghai, 200011, China
-
GSK Investigational Site
Shanghai, 200040, China
-
GSK Investigational Site
Shanghai, 200065, China
-
GSK Investigational Site
Shenyang, 110022, China
-
GSK Investigational Site
Shijiazhuang, 050051, China
-
GSK Investigational Site
Tianjin, 300192, China
-
GSK Investigational Site
Zhuzhou, 412007, China
-
GSK Investigational Site
Dax, 40107, France
-
GSK Investigational Site
La Roche-sur-Yon, 85925, France
-
GSK Investigational Site
La Rochelle, 17019, France
-
GSK Investigational Site
Montpellier, 34000, France
-
GSK Investigational Site
Paris, 75012, France
-
GSK Investigational Site
Berlin, 10117, Germany
-
GSK Investigational Site
Hamburg, 20095, Germany
-
GSK Investigational Site
Hamburg, 22415, Germany
-
GSK Investigational Site
Magdeburg, 39120, Germany
-
GSK Investigational Site
Fukuoka, 834-0115, Japan
-
GSK Investigational Site
Ibaraki, 300-1234, Japan
-
GSK Investigational Site
Ibaraki, 300-1253, Japan
-
GSK Investigational Site
Nagano, 390-8601, Japan
-
GSK Investigational Site
Nagano, 395-8505, Japan
-
GSK Investigational Site
Osaka, 543-0027, Japan
-
GSK Investigational Site
Saitama, 330-0074, Japan
-
GSK Investigational Site
Shimane, 693-8501, Japan
-
GSK Investigational Site
Tokyo, 103-0027, Japan
-
GSK Investigational Site
Tokyo, 104-0031, Japan
-
GSK Investigational Site
Tokyo, 113-8431, Japan
-
GSK Investigational Site
Chihuahua City, 31000, Mexico
-
GSK Investigational Site
Guadalajara, 44650, Mexico
-
GSK Investigational Site
Mexicali, 21200, Mexico
-
GSK Investigational Site
Mérida, CP 97070, Mexico
-
GSK Investigational Site
Torreón, 27000, Mexico
-
GSK Investigational Site
Cape Town, 7130, South Africa
-
GSK Investigational Site
Cape Town, 7405, South Africa
-
GSK Investigational Site
Gauteng, 1619, South Africa
-
GSK Investigational Site
Johannesburg, 2113, South Africa
-
GSK Investigational Site
Stellenbosch, 7600, South Africa
-
GSK Investigational Site
Seoul, 03080, South Korea
-
GSK Investigational Site
Seoul, 06973, South Korea
-
GSK Investigational Site
Seoul, 07441, South Korea
-
GSK Investigational Site
A Coruña, 15006, Spain
-
GSK Investigational Site
Barcelona, 08430, Spain
-
GSK Investigational Site
Barcelona, 08540, Spain
-
GSK Investigational Site
Madrid, 28046, Spain
-
GSK Investigational Site
Santander, 39008, Spain
-
GSK Investigational Site
Santiago de Compostela, 15702, Spain
-
GSK Investigational Site
Seville, 41014, Spain
-
GSK Investigational Site
Blackpool, FY2 0JH, United Kingdom
-
GSK Investigational Site
Cannock, WS11 0BN, United Kingdom
-
GSK Investigational Site
London, EN5 3DJ, United Kingdom
-
GSK Investigational Site
Manchester, M13 9NQ, United Kingdom
Conditions
Explore the condition pages connected to this study.